Pancreatic Neoplasms
1 competing product in clinical development for Pancreatic Neoplasms.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| GEMZAR + ALIMTA | Eli Lilly | Phase 3 | Completed | 77 |
1 competing product in clinical development for Pancreatic Neoplasms.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| GEMZAR + ALIMTA | Eli Lilly | Phase 3 | Completed | 77 |